Colitis Crohn Articles & Analysis
3 news found
Microbiotica, a leading player in microbiome-based therapeutics and biomarkers, today announces it has received project funding from the Crohn’s & Colitis Foundation, as part of their IBD Ventures program, for the development of therapies to treat inflammatory bowel disease (IBD). ...
Vedanta plans to move this consortium forward to a Phase 2 study in patients with ulcerative colitis. The study will be partially funded with the proceeds from a $25 million investment from Pfizer, as part of the Pfizer Breakthrough Growth Initiative, which was announced in January 2021. ...
Eleven outstanding community volunteers have been named ABC/13 Women of Distinction and Ambassador for the 2011 Winter Ball, benefiting the Crohn's & Colitis Foundation of America (CCFA) Houston Gulf Coast/South Texas Chapter. ...